Stephen Ehikian is taking over as CEO, succeeding Thomas Siebel, who revealed that he was diagnosed with an autoimmune disease.
Related Posts
Even with high tariffs, Trump’s trade war suddenly is starting to look not so scary on Wall Street
Economists cite several factors as reasons for why the landscape looks less dire.
SoftBank Group shares surge 13% to a record high after quarterly profit beat estimates
The Japanese investment firm gained for a fourth straight session, and closed at a record high on Thursday, before its earnings release.
Congress has power over tariffs, but stopping Trump isn’t likely as of now
Stock market indices have sharply fallen on the heels of President Trump imposing higher tariffs on more than 180 countries.